-
1 Comment
Wanjia Group Holdings Limited is currently in a long term downtrend where the price is trading 10.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
Wanjia Group Holdings Limited's total revenue sank by 0.6% to $51M since the same quarter in the previous year.
Its net income has increased by 66.2% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 120.2% to $3M since the same quarter in the previous year.
Based on the above factors, Wanjia Group Holdings Limited gets an overall score of 3/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG9431A1186 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Dividend Yield | None |
|---|---|
| Market Cap | 45M |
| Target Price | None |
| Beta | 0.61 |
Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0401.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
